https://www.selleckchem.com/products/prt543.html
011) and relapse earlier than 365days post-transplantation (HR 2.101, P.001 for 0-180days; HR 1.522, P=.041 for 181-365days) were found in multivariate analysis to be significant prognostic factors for outcome. The type of salvage therapy in chemosensitive relapse was identified as a significant prognostic factor for OS. A salvage approach with curative intent may be considered for patients with post-transplant relapse, even if they relapse in the first year post-transplantation. For sustainable remission, a second allo-HSCT may be r
Like
Comment
Share
